← All stocks

Revolution Medicines, Inc.

RVMD Mostly scheduled
CIK 0001628171 #590 in the set updated 21 Sep 2026
Bought (12 mo)
$0.00
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$152.31M
$30.47M on a plan · $121.11M straight out of an exercise
Sold at will
$720.49K
1 of 149 sales
Net
−$152.31M
−$720.49K against sales at will

By person

18 insiders · 150 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
GOLDSMITH MARK A
See Remarks
$56.99M (45) scheduled
−$56.99M
376,190
0.1755%
$74.98M
+68.0%
Horn Margaret A
Chief Operating Officer
$25.25M (16) scheduled
−$25.25M
149,680
0.0698%
$29.83M
+12.0%
Kelsey Stephen Michael
See Remarks
$22.55M (14) scheduled
−$22.55M
286,307
0.1336%
$57.06M
+7.8%
Cislini Jeff
SVP & General Counsel
$15.19M (16) scheduled
−$15.19M
52,541
0.0245%
$10.47M
+13.6%
Kim Lorence H.
Director
$14.97M (14) scheduled
−$14.97M
1,191
0.0006%
$237.37K
−98.3%
Mancini Anthony
See Remarks
$8.70M (19) scheduled
−$8.70M
42,116
0.0196%
$8.39M
−22.9%
Anders Jack
Chief Financial Officer
$7.13M (12) scheduled
−$7.13M
119,216
0.0556%
$23.76M
+18.9%
Patel Sushil
Director
$1.05M (9) scheduled
−$1.05M
21,656
0.0101%
$4.32M
+8.6%
Wei Lin
Chief Medical Officer
$206.22K (1) scheduled
−$206.22K
101,366
0.0473%
$20.20M
−10.7%
Wang Xiaolin
See Remarks
$199.96K (1) scheduled
−$199.96K
116,063
0.0541%
$23.13M
+33.9%
Sandler Alan B.
Chief Development Officer
$67.94K (2) scheduled
−$67.94K
52,868
0.0247%
$10.54M
−0.6%
Borisy Alexis
Director
2,340,075
1.09%
$466.38M
+0.2%
Schroeder Thilo
Director
760,869
0.3550%
$151.64M
Horning Sandra
Director
97,765
0.0456%
$19.48M
+4.6%
Borellini Flavia
Director
26,215
0.0122%
$5.22M
+19.8%
ANDERSON ELIZABETH M
Director
24,406
0.0114%
$4.86M
+21.6%
Weber Barbara
Director
13,065
0.0061%
$2.60M
−28.5%
Clyburn Frank
Director
10,929
0.0051%
$2.18M
+57.7%
Insider
Date
Role
Action
Shares
Price
Amount
Mancini Anthony
16 Jun 2026
See Remarks
Sell
4,615
$156.12
$720.49K

What was left out

Form 4 filings counted 68
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 47
Sales straight out of an exercise 101
Sales at will 1
Transactions with no price 0
Shares from compensation/vesting 1,282,173
History held since 14 Feb 2020